Master in PHARMACEUTICAL BIOTECHNOLOGIES

Tuition is 2,863 USD per year.

Pharmaceutical Biotechnologies is a master's program delivered in English at Università degli Studi del Piemonte Orientale, based in Vercelli, Italy, over a two-year course of study. Pharmaceutical biotechnology sits at the intersection of biology, chemistry and pharmaceutical science, focusing on how living cells, enzymes and biological systems are used to develop, produce and test drugs and other therapeutic products. Students in this field typically study molecular biology, biochemistry, microbiology, pharmacology and the regulatory and quality-control processes that govern how biological medicines, such as vaccines, monoclonal antibodies, and recombinant proteins, move from laboratory research to approved products. Coursework often includes genetic engineering techniques, cell culture methods, fermentation and bioprocessing, drug delivery systems, and the analytical methods used to characterize biopharmaceuticals. Because the pharmaceutical industry depends heavily on biotechnological methods for developing new treatments, graduates from this area are prepared for roles in research and development, quality assurance, regulatory affairs, and production within pharmaceutical and biotech companies, as well as in academic or public research laboratories. Some proceed to further specialization or doctoral study, particularly in areas connected to drug discovery or biomanufacturing. Vercelli, where the university is based, is a city in the Piedmont region of northern Italy, and studying this master's program in English allows international students to engage with a scientifically rigorous curriculum in a smaller academic setting outside Italy's larger metropolitan centers. The program builds on an undergraduate foundation in life sciences or a related discipline, preparing graduates for technical and scientific careers connected to the development of biological medicines.